HeartSciences Share Holder Equity 2022-2024 | HSCS
HeartSciences Annual Share Holder Equity (Millions of US $) |
|
---|---|
2023 | $0 |
2022 | $-6 |
2021 | $-2 |
HeartSciences Quarterly Share Holder Equity (Millions of US $) |
|
---|---|
2024-01-31 | $9 |
2023-10-31 | $-2 |
2023-07-31 | $-1 |
2023-04-30 | $0 |
2023-01-31 | $-0 |
2022-10-31 | $1 |
2022-07-31 | $3 |
2022-04-30 | $-6 |
2022-01-31 | $0 |
2021-10-31 | $0 |
2021-07-31 | $0 |
2021-04-30 | $-2 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.004B | $0.000B |
HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $36.800B | 20.21 |
Inspire Medical Systems (INSP) | United States | $4.798B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.473B | 0.00 |
Axonics (AXNX) | United States | $3.450B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $2.982B | 0.00 |
10x Genomics (TXG) | United States | $2.868B | 0.00 |
IRhythm Technologies (IRTC) | United States | $2.818B | 0.00 |
Enovis (ENOV) | United States | $2.800B | 20.75 |
Azenta (AZTA) | United States | $2.749B | 154.58 |
Privia Health (PRVA) | United States | $1.962B | 109.60 |
Schrodinger (SDGR) | United States | $1.646B | 0.00 |
Omnicell (OMCL) | United States | $1.481B | 51.17 |
Phreesia (PHR) | United States | $1.301B | 0.00 |
Standard BioTools (LAB) | United States | $0.958B | 0.00 |
Definitive Healthcare (DH) | United States | $0.668B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.506B | 0.00 |
Talkspace (TALK) | United States | $0.468B | 0.00 |
Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
Pulmonx (LUNG) | United States | $0.347B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.307B | 0.00 |
Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
Outset Medical (OM) | United States | $0.202B | 0.00 |
P3 Health Partners (PIII) | United States | $0.159B | 0.00 |
American Well (AMWL) | United States | $0.147B | 0.00 |
TruBridge (TBRG) | United States | $0.139B | 7.47 |
111 (YI) | China | $0.107B | 0.00 |
MSP Recovery (LIFW) | United States | $0.100B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.062B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
Augmedix (AUGX) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.046B | 0.00 |
CareCloud (CCLD) | United States | $0.044B | 0.00 |
Movano (MOVE) | United States | $0.041B | 0.00 |
Akili (AKLI) | United States | $0.033B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
Cue Health (HLTH) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |